Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-21

FDA Approved: DESMOPRESSIN ACETATE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved desmopressin acetate from Aurobindo Pharma Limited under an original abbreviated new drug application (ANDA213095).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desmopressin Acetate (Desmopressin acetate)

Snippet

ORIG AP for DESMOPRESSIN ACETATE (DESMOPRESSIN ACETATE)